Serum Thymus and Activation-regulated Chemokine (TARC) Level Monitoring May Predict Disease Relapse Detected by PET Scan After Reduced Intensity Allogeneic Stem Cell Transplantation in Hodgkin's Lymphoma Patients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT02069639

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:35:32.847254+00:00

Published At

2014-02-24T00:00:00+00:00

Record Updated At

2014-02-24

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Hodgkin\u0027s Lymphoma Patients Who Underwent an Allogeneic Stem Cell Transplantation"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2014-02-24"

protocolSection.identificationModule.nctId

"NCT02069639"

protocolSection.identificationModule.officialTitle

"Serum Thymus and Activation-regulated Chemokine (TARC) Level Monitoring May Predict Disease Relapse Detected by PET Scan After Reduced Intensity Allogeneic Stem Cell Transplantation in Hodgkin\u0027s Lymphoma Patients"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

[]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Hodgkin's Lymphoma Patients Who Underwent an Allogeneic Stem Cell Transplantation (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.